Claims
- 1. Sulfonamide derivatives of the formula (I) or pharmacologically acceptable salts thereof: ##STR139## wherein: R.sup.1 represents a hydrogen atom, halogen atom, lower alkyl group, lower alkoxy group, hydroxyl group, nitro group, phenoxy group, cyano group, acetyl group, amino group or a protected amino group, R.sup.2 and R.sup.3 may be the same or different from each other and each represent a hydrogen atom, halogen atom, lower alkyl group or lower alkoxy group, R.sup.4 and R.sup.7 may be the same or different from each other and each represents a hydrogen atom or a lower alkyl group, R.sup.5 and R.sup.6 may be the same or different from each other and each represents a hydrogen atom, halogen atom, lower alkoxy group, amino group or amino group substituted with a lower alkyl or a phenyl group, A is .dbd.CH--, B is .dbd.N--, and E is ##STR140## in which Q represents an oxygen atom or a sulfur atom and R" is a phenyl group or a phenyl group having from 1 to 3 substituents, said substituents being the same or different from one another and selected from the group consisting of a halogen atom, lower alkyl group, lower alkoxy group, hydroxyl group, protected hydroxyl group, carboxyl group, esterified carboxyl group, amidated carboxyl group, lower alkylthio group and phenoxy group.
- 2. Sulfonamide derivatives or pharmacologically acceptable salts thereof according to claim 1, wherein R.sup.1 represents a lower alkoxy group.
- 3. Sulfonamide derivatives or pharmacologically acceptable salts thereof according to claim 1, wherein the compound is N-[3-(4-Methoxybenzenesulfonamido)-2-pyridyl]-2-methylbenzamide.
- 4. A pharmacological composition which comprises a pharmacologically effective amount of the derivative as defined in claim 1 and a pharmacologically acceptable carrier.
Priority Claims (3)
Number |
Date |
Country |
Kind |
2-218710 |
Aug 1990 |
JPX |
|
3-38509 |
Mar 1991 |
JPX |
|
3-121041 |
May 1991 |
JPX |
|
Parent Case Info
This is a division of Ser. No. 08/085,962, filed Jun. 30, 1993, now U.S. Pat. No. 5,332,751 which is a division of Ser. No. 07/923,345, filed Jul. 31, 1992, now U.S. Pat. No. 5,292,758 which is a division of Ser. No. 07/742,618 filed Aug. 8, 1991, now U.S. Pat. No. 5,250,549.
Foreign Referenced Citations (3)
Number |
Date |
Country |
0215200A3 |
Mar 1987 |
EPX |
0263229A1 |
Apr 1988 |
EPX |
1670761 |
Dec 1970 |
DEX |
Non-Patent Literature Citations (3)
Entry |
Chemical Abstracts, vol. 96, No. 21. Abstract 190.694q p. 672 May 24, 1982. |
Beilsteins Handbuch Der Organischen Chemie, 4th Edition, 3rd Supplement, vol. 14, Part 3, 1974, pp. 2092-2093. |
J. Med. Pharm. Chem., vol. 1, No. 3, 1959, pp. 197-210, M. C. Kloetzel, et al. |
Divisions (3)
|
Number |
Date |
Country |
Parent |
85962 |
Jun 1993 |
|
Parent |
923345 |
Jul 1992 |
|
Parent |
742618 |
Aug 1991 |
|